. Interaction between growth hormone and insulin in the regulation of lipoprotein metabolism in the rat. Am J Physiol Endocrinol Metab 283: E1023-E1031, 2002. First published July 30, 2002 10.1152/ajpendo.00260.2002The importance of insulin for the in vivo effects of growth hormone (GH) on lipid and lipoprotein metabolism was investigated by examining the effects of GH treatment of hypophysectomized (Hx) female rats with and without concomitant insulin treatment. Hypophysectomy-induced changes of HDL, apolipoprotein (apo)E, LDL, and apoB levels were normalized by GH treatment but not affected by insulin treatment. The hepatic triglyceride secretion rate was lower in Hx rats than in normal rats and increased by GH treatment. This effect of GH was blunted by insulin treatment. The triglyceride content in the liver changed in parallel with the changes in triglyceride secretion rate, indicating that the effect of the hormones on triglyceride secretion was dependent on changed availability of triglycerides for VLDL assembly. GH and insulin independently increased editing of apoB mRNA, but the effects were not additive. The expression of fatty-acid synthase (FAS), stearoyl-CoA desaturase-1 (SCD-1), and sterol regulatory element-binding protein-1c (SREBP-1c) was increased by GH treatment. Insulin and GH had no additive effects on these genes; instead, insulin blunted the effect of GH on SREBP-1c mRNA. In contrast to the liver, adipose tissue expression of SREBP-1c, FAS, or SCD-1 mRNA was not influenced by GH. In conclusion, the increased hepatic expression of lipogenic enzymes after GH treatment may be explained by increased expression of SREBP-1c. Insulin does not mediate the effects of GH but inhibits the stimulatory effect of GH on hepatic SREBP-1c expression and triglyceride secretion rate. apolipoprotein B; apolipoprotein E; apoB mRNA editing; triglyceride secretion; sterol regulatory element-binding protein-1; fatty-acid synthase; stearoyl-CoA desaturase; liver; adipose tissue IT IS WELL KNOWN THAT GROWTH HORMONE (GH) has marked effects on lipid and lipoprotein metabolism (1, 30). GH also increases secretion (27, 32) and plasma levels of insulin in humans and rats (31,32,37,44). Moreover, GH increases DNA synthesis and proliferation of -cells and insulin secretion in vitro (27), showing that GH enhances -cell function independently of its insulin-antagonistic action (34,35,45). The increased serum insulin levels and the insulin-antagonistic effect of GH may be of importance for several effects of GH in vivo, but few studies have addressed this question (31,36). Treatment of normal rats with the combination of insulin and GH results in an additive effect on body weight gain. However, GH treatment antagonizes the stimulatory effects of insulin on food intake and adipose tissue weight, indicating a complex interaction between GH and insulin (36).The interaction of insulin and GH in the regulation of lipid and lipoprotein metabolism is of special interest, because similar effects of GH and chronic hyperinsulinemia...